Drug company 'may take legal action against NHS'

Two drug companies have attacked as "arbitrary and disappointing" a decision to remove cancer treatments they make from the list covered by a special fund in England.

The Cancer Drugs Fund provides treatment which would not routinely be available to thousands of NHS patients, because the are deemed too expensive by the watchdog NICE.

Gary Hendler is president and CEO of Eisai Europe Middle East and Africa, and he spoke to the Today programme.